How To Prepare DSCSA 3PL FDA Annual Reporting
DSCSA 3PL FDA Annual Reporting
Definition
Annual reporting to FDA by covered prescription-drug third-party logistics providers regarding licensure and facility information.
Overview
DSCSA 3PL FDA Annual Reporting requires covered third-party logistics providers to collect and submit accurate licensure and facility details to the FDA on a yearly basis. Preparation is mostly administrative but must be methodical to avoid regulatory friction and to protect supply-chain partners.
Begin preparation by establishing a repeatable workflow. Assign a compliance lead, create a master inventory of covered facilities, confirm state license statuses, and collect point-of-contact details. The following sections break down the tasks, timings, and practical checks warehouses and 3PLs should use.
Pre-Reporting Checklist
- Inventory Of Facilities: Compile every physical location performing covered activities—storage, distribution, kitting, labeling, returns handling—and include facility identifiers.
- License Verification: Pull copies of current state 3PL/wholesale distributor licenses and note their numbers and expiration dates.
- Designated Contact: Identify the responsible corporate officer or compliance contact with direct phone and email for regulatory correspondence.
Data Sources And Records To Use
Trusted records reduce rework. Use internal documents and state licensing databases to verify data. Maintain scanned copies of licenses and use an internal reconciliation spreadsheet to compare what you hold versus what state registries show. If your business operates under multiple legal entities, map each facility to the correct legal name and tax identification to prevent mismatches in FDA records.
Filing Process And Timing
The FDA sets the filing window and accepted submission formats. Although the mechanics can change, standard practice is to prepare data early and submit within the agency’s designated period. If the FDA provides an online portal or form for 3PL reporting, confirm access credentials well before the filing window. If a manual or email-based submission is required, plan internal review steps and sign-off procedures to ensure completeness.
Quality-Control Steps Before Submission
- Cross-Check Licenses: Verify license numbers against state board or controlled-substance registries where applicable.
- Validate Addresses: Confirm physical addresses (not PO boxes) because FDA uses facility location for inspections and incident response.
- Confirm Services: Ensure the listed operational roles match contractual statements with manufacturers, wholesalers, or other clients.
Coordinating With Customers
Manufacturers and distributors often require copies of their logistics partners’ compliance records. Proactively share the dates you intend to file, which contact will sign off, and offer to provide a redacted copy of the submission if contractual confidentiality allows. This reduces audit friction and helps customers validate their own supply-chain records.
Recordkeeping After Submission
Keep an archived copy of the submitted dataset, the confirmation receipt (if provided), and any correspondence with the FDA. Retain underlying license documents and the reconciliation workbook for at least the period recommended by your compliance policy—commonly three to five years—so auditors and partners can verify the submission’s accuracy.
Practical Example
A medium-sized 3PL with four distribution centers builds a simple annual routine: 1) compliance lead runs a facility roster report, 2) operations confirms roles at each site, 3) legal pulls state licenses and notes expirations, 4) the compliance lead compiles a single submission file, and 5) a company officer signs and files within the FDA window. The team stores the packet in a compliance vault along with calendar reminders for license renewals.
Tips To Reduce Risk
- Label: Start early: Begin verification 90 days before the filing window and lock final data 14 days before submission.
- Label: Use version control: Keep snapshots of the dataset to show how corrections were made if questions arise.
- Label: Coordinate IT and compliance: If the FDA uses an electronic portal, test credentials and file formats ahead of time to avoid last-minute technical issues.
In short, the DSCSA 3PL FDA Annual Reporting is an annual, structured process. With standardized checklists, cross-checks against state records, and routine coordination with customers, warehouses and 3PLs can complete their submissions accurately and on time, minimizing regulatory and commercial risk.
Sources And Additional Reading (3)
- Drug Supply Chain Security Act (DSCSA)
“Drug Supply Chain Security Act (DSCSA).” U.S. Food and Drug Administration, https://www.fda.gov/drugs/drug-supply-chain-security-act-dscsa.
- Drug Quality and Security Act (DQSA)
“Drug Quality and Security Act (DQSA).” U.S. Food and Drug Administration, https://www.fda.gov/drugs/drug-supply-chain-integrity/drug-quality-and-security-act-dqsa.
- Establishment Registration and Drug Listing for FDA-Regulated Products
“Establishment Registration and Drug Listing for FDA-Regulated Products.” U.S. Food and Drug Administration, https://www.fda.gov/drugs/drug-approvals-and-databases/establishment-registration-and-drug-listing-fda-regulated-products.
More from this term
Looking for a 3PL?
Compare warehouses on Racklify and find the right logistics partner for your business.